| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.38 | 5e-18 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.16 | 5e-05 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.16 | 0.0004 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.17 | 0.001 |